Tevogen Inc.
TVGN· Nasdaq
Filed Nov 14, 2022 · 10-Q · 45 days after period end · 0001410578-22-003394
| Metric | Q3 2022 | Q3 2021 |
|---|---|---|
| Net Income | $1.61M | -$115.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tevogen Inc. · CIK 1860871 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 14, 2022 · 45 d after period end